Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
Rhea-AI Summary
Prenetics (NASDAQ: PRE) named Formula 1 driver Ollie Bearman as Global Ambassador and shareholder on Feb 13, 2026. IM8, co-founded by David Beckham, achieved US$100 million ARR in 11 months and cites NSF Certified for Sport® designation for its Daily Ultimate Essentials.
The partnership follows Bearman’s reported use of IM8 products and aligns the brand with elite athletes and a noted Scientific Advisory Board.
Positive
- US$100 million ARR achieved in 11 months
- Ollie Bearman joins as ambassador and shareholder
- NSF Certified for Sport® designation for Daily Ultimate Essentials
- Scientific Advisory Board includes Mayo Clinic and Cedars-Sinai experts
Negative
- None.
News Market Reaction
On the day this news was published, PRE gained 4.82%, reflecting a moderate positive market reaction. This price movement added approximately $17M to the company's valuation, bringing the market cap to $370M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Momentum scanner shows 1 peer (FLGT) moving down 4.35% with no peers in the same direction as the target flag; broader sector names in Diagnostics & Research are mixed, indicating stock-specific dynamics.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 11 | Earnings date set | Neutral | -0.1% | Scheduled Q4 and full-year 2025 results and earnings call on Feb 18, 2026. |
| Jan 06 | Business divestiture | Positive | +2.8% | Divested Europa for up to $13M to focus on IM8 with strong liquidity and 2026 IM8 guidance. |
| Jan 05 | Warrant exchange update | Positive | +0.4% | High 86.7% participation in warrant exchange, reducing potential dilution and simplifying structure. |
| Dec 30 | Capital allocation shift | Neutral | -3.3% | Ceased Bitcoin purchases to concentrate capital on IM8 growth while keeping 510 BTC treasury. |
| Dec 23 | Warrant exchange deals | Positive | -6.9% | Voluntary warrant exchange to cut outstanding warrants and potential dilution to shareholders. |
Recent corporate and capital-structure news has usually seen price moves align with generally positive messaging, with one notable divergence on warrant exchange news.
Over the last few months, Prenetics has pivoted decisively toward its IM8 brand, including divesting Europa for up to $13 million and highlighting IM8’s projected $180–$200 million 2026 revenue. Capital-structure work via warrant exchanges aimed to reduce potential dilution, while a capital allocation shift ended Bitcoin purchases but retained 510 BTC. An upcoming Q4/FY2025 earnings call on Feb 18, 2026 follows today’s ambassador/shareholder announcement, reinforcing the company’s emphasis on IM8-driven growth and brand building.
Market Pulse Summary
This announcement underscores Prenetics’ emphasis on IM8’s brand-building, adding a rising Formula 1 driver as both ambassador and shareholder after IM8 reached US$100 million ARR in 11 months. It follows recent divestitures and warrant exchanges that refocused the company on IM8. Investors may watch how this endorsement translates into revenue growth, as well as the upcoming Q4/FY2025 results on Feb 18, 2026 for clearer indications of IM8’s trajectory.
Key Terms
annual recurring revenue financial
nsf certified for sport® regulatory
AI-generated analysis. Not financial advice.
- Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand’s mission and products.
- IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.
- IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US
$100 million in Annual Recurring Revenue in just 11 months from launch. - Bearman’s rapid rise – including a historic points-scoring Ferrari debut at just 18—cements his reputation as one of motorsport’s brightest young talents.
NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced Formula 1 phenom Ollie Bearman as its newest Global Ambassador and a shareholder. This partnership marks another milestone for IM8 as it continues to capture interest and align with world-class athletes who embody peak performance and a commitment to health excellence.
At just 18 years old, Bearman made a historic entrance into Formula 1 when he was called up on short notice to drive for Ferrari at the 2024 Saudi Arabian Grand Prix, finishing an impressive 7th and becoming the youngest British driver ever to start a World Championship Grand Prix. That breakthrough performance marked him as one of the youngest drivers in modern F1 history to score points on debut. Prior to his F1 opportunity, he delivered standout results across the junior ranks, including 17 race wins in a single Formula 4 season and multiple Formula 2 victories at iconic circuits such as Baku and Barcelona. Those accomplishments paved the way for his first full Formula 1 season in 2025, where he gained valuable experience and further demonstrated maturity and composure beyond his years. He now enters his second full season in Formula 1 as the 2026 campaign begins and continuing his trajectory as one of the sport’s most exciting young talents and a genuine generational prospect.
The collaboration with IM8 was initiated after Ollie experienced significant performance benefits from incorporating IM8’s flagship product, Daily Ultimate Essentials, into his rigorous training and competition schedule. The product’s NSF Certified for Sport® designation provided the assurance of quality and safety required by an athlete competing at the highest level of motorsport.
"In Formula 1, every millisecond counts, and the physical and mental demands are immense. Your body and mind have to operate at their absolute peak," said Ollie Bearman. "I was introduced to IM8 and was immediately impressed by the science and the quality of the experts they work with. After using the product, I felt a noticeable difference in my energy levels, focus on the track, and recovery between races. Trust is critical in my world, and IM8’s commitment to the NSF Certified for Sport® certification gives me complete confidence. I’m not just endorsing this brand; I’m investing in it because I believe in the product and the team. It’s an honor to join David Beckham and the IM8 family to share the importance of foundational health with a global audience."
Danny Yeung, CEO of Prenetics, commented, "We are thrilled to welcome Ollie Bearman to the IM8 and Prenetics family. Ollie is someone who has already delivered extraordinary performances at an age when most drivers are still years away from Formula 1. His composure under pressure, rapid rise through the ranks, and historic Ferrari debut make him exactly the kind of next-generation athlete IM8 stands for.
At just 20 years old, he already understands that peak performance starts with the right foundation, and that mindset is exactly what IM8 represents. The fact that this partnership developed organically, with Ollie first being a genuine user of the product, speaks volumes about the efficacy and trust that IM8 has built. Having a young driver with his ambition and potential not only as an ambassador but also as a shareholder is incredibly exciting and reinforces our mission to provide best-in-class, science-backed nutritional supplements to the next generation of athletes and health-conscious consumers worldwide.”
IM8 has demonstrated unprecedented growth since its launch in December 2024, establishing itself as a major force in the global supplement market. The brand’s success is built on a foundation of scientific credibility, with a Scientific Advisory Board that includes experts from world-renowned institutions such as the Mayo Clinic, Cedars-Sinai and more.
IM8’s Daily Ultimate Essentials is available at www.im8health.com.
Press Kit: HERE
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, surpassing
About IM8
IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5e271944-1a7a-442d-8486-6a6185ed530f
https://www.globenewswire.com/NewsRoom/AttachmentNg/d177408a-3238-4bfc-8e1a-57a4e7ad1e6a
FAQ
What did Prenetics announce about Ollie Bearman on Feb 13, 2026 (PRE)?
How fast did IM8 reach US$100 million ARR and what does that mean for PRE?
Which IM8 product did Ollie Bearman use and why is certification important for PRE investors?
Does Ollie Bearman’s role as shareholder affect Prenetics’ ownership structure (PRE)?
What credibility does IM8 claim to support its supplements and PRE’s growth?
